国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Acetyl-coenzyme A synthetase (acs), partial CSB-YP001203YAK
CSB-EP001203YAK
CSB-BP001203YAK
CSB-MP001203YAK
CSB-EP001203YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Oligoribonuclease (orn) CSB-YP019586YAK
CSB-EP019586YAK
CSB-BP019586YAK
CSB-MP019586YAK
CSB-EP019586YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Translation initiation factor IF-2 (infB), partial CSB-YP015164YAK
CSB-EP015164YAK
CSB-BP015164YAK
CSB-MP015164YAK
CSB-EP015164YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Ferrochelatase (hemH) CSB-YP008579YAK
CSB-EP008579YAK
CSB-BP008579YAK
CSB-MP008579YAK
CSB-EP008579YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Queuine tRNA-ribosyltransferase (tgt) CSB-YP019146YAK
CSB-EP019146YAK
CSB-BP019146YAK
CSB-MP019146YAK
CSB-EP019146YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Thymidylate synthase (thyA) CSB-YP025393YAK
CSB-EP025393YAK
CSB-BP025393YAK
CSB-MP025393YAK
CSB-EP025393YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Glycine cleavage system H protein (gcvH) CSB-YP009335YAK
CSB-EP009335YAK
CSB-BP009335YAK
CSB-MP009335YAK
CSB-EP009335YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Cardiolipin synthase (cls), partial CSB-YP005985YAK1
CSB-EP005985YAK1
CSB-BP005985YAK1
CSB-MP005985YAK1
CSB-EP005985YAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Galactokinase (galK) CSB-YP009198YAK
CSB-EP009198YAK
CSB-BP009198YAK
CSB-MP009198YAK
CSB-EP009198YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Glycogen debranching enzyme (glgX), partial CSB-YP001446YAK
CSB-EP001446YAK
CSB-BP001446YAK
CSB-MP001446YAK
CSB-EP001446YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Urocanate hydratase (hutU), partial CSB-YP025677YAK
CSB-EP025677YAK
CSB-BP025677YAK
CSB-MP025677YAK
CSB-EP025677YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B Beta-galactosidase (lacZ), partial CSB-YP009476YAK
CSB-EP009476YAK
CSB-BP009476YAK
CSB-MP009476YAK
CSB-EP009476YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B ATP synthase subunit alpha (atpA), partial CSB-YP002344YAK
CSB-EP002344YAK
CSB-BP002344YAK
CSB-MP002344YAK
CSB-EP002344YAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. ATP synthase subunit delta (atpH) CSB-YP002355AVL
CSB-EP002355AVL
CSB-BP002355AVL
CSB-MP002355AVL
CSB-EP002355AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. ATP synthase subunit beta (atpD) CSB-YP002350AVL
CSB-EP002350AVL
CSB-BP002350AVL
CSB-MP002350AVL
CSB-EP002350AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. Queuine tRNA-ribosyltransferase (tgt) CSB-YP019146AVL
CSB-EP019146AVL
CSB-BP019146AVL
CSB-MP019146AVL
CSB-EP019146AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. Peptide chain release factor 1 (prfA) CSB-YP015197AVL
CSB-EP015197AVL
CSB-BP015197AVL
CSB-MP015197AVL
CSB-EP015197AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. Glycine cleavage system H protein (gcvH) CSB-YP009335AVL
CSB-EP009335AVL
CSB-BP009335AVL
CSB-MP009335AVL
CSB-EP009335AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. Triosephosphate isomerase (tpiA) CSB-YP024102AVL
CSB-EP024102AVL
CSB-BP024102AVL
CSB-MP024102AVL
CSB-EP024102AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azoarcus sp. Ribosome-recycling factor (frr) CSB-YP014941AVL
CSB-EP014941AVL
CSB-BP014941AVL
CSB-MP014941AVL
CSB-EP014941AVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>